Vista Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 34.7 million. Revenue was INR 35.49 million. Net loss was INR 20.19 million compared to INR 2.4 million a year ago. Basic loss per share from continuing operations was INR 0.46 compared to INR 0.08 a year ago.
For the six months, sales was INR 54.51 million. Revenue was INR 56.63 million. Net loss was INR 29.74 million compared to INR 8.3 million a year ago. Basic loss per share from continuing operations was INR 0.72 compared to INR 0.27 a year ago.